http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#Head http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#assertion http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#provenance http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#pubinfo http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#assertion http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:88439 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://amigo.geneontology.org/amigo/term/GO:0006954 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/decreases http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_1 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#assertion http://www.w3.org/2000/01/rdf-schema#label p(MGI:Cntf) -| bp(GOBP:"inflammatory response") http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_4 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_3 http://www.w3.org/ns/prov#value In human peripheral blood mononuclear cells, ciliary neurotrophic factor (CNTF) weakly suppressed endotoxin-induced interleukin (IL)-1 and prostaglandin E2(PGE2). Suppression of PGE2 and IL-8 synthesis was significantly greater (up to 42.6%, P < 0.05) by adding a 10-fold molar excess of soluble CNTF receptor (sCNTFR alpha). In cultured human fibroblasts, CNTF at 12 micrograms/ml did not suppress IL-1 alpha-induced IL-8. However, in the presence of a 10-fold excess of sCNTFR alpha, 300 ng/ml of CNTF suppressed IL-1 alpha-induced IL-8 by 44%. Therefore, sCNTFR alpha can confer to CNTF anti-inflammatory properties in vitro. IL-6 which, like CNTF, utilizes the gp130 signal transducer, possesses similar inhibitory effects. That CNTF and IL-6 share gp130 as a receptor component suggests that gp130 mediates these anti-inflammatory responses. http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/7957680 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/7957680 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#_3 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ#pubinfo http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://purl.org/dc/terms/created 2014-07-03T14:33:48.166+02:00 http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAqouiVY6lxG0mE0mSbOQkzaERwOlqTuw6jl1fRlUG4wQ http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234